This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Vitamin E has antioxidant activity that inhibits subendothelial low-density lipoprotein oxidation and atherosclerotic plaque formation.¹ Nevertheless, current opinion does not advocate the use of daily vitamin E supplementation to reduce the risk of vascular events² and the skepticism concerning the use of vitamin E as an adjunctive treatment for either secondary or primary prevention of vascular events is based on the present "lack of solid evidence of efficacy."² However, a careful overview of the data allows for an alternative approach, which is based on several considerations.

First, data from animal experiments strongly support the efficacy of vitamin E in reducing the number and size of atherosclerotic plaques,¹ and compelling data from human studies demonstrate protection of low-density lipoproteins from lipid peroxidation by a minimum dose of vitamin E (400 IU), but not by using beta carotene.^3-5 Second, the equivocal results of both the Alpha-Tocopherol, Beta Carotene Cancer Prevention Study (ATBC)⁶ . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?